Site-directed mutagenesis was performed to create a mutant serotonin 5
-HT2C receptor that would mimic the active conformation of the native
receptor, Structural alteration of receptor conformation was achieved
by changing amino acid no. 312 from serine to phenylalanine (S312F) or
lysine (S312K), After expression in COS-7 cells, the binding affinity
of 5-HT for [H-3]-mesulergine-labeled 5-HT2C receptors increased from
203 nM (native) to 76 nM for S312F and 6.6 nM for S312K mutant recept
ors. 5-HT potency for stimulation of phosphatidylinositol (PI) hydroly
sis increased from 70 nM (native) to 28 nM for S312F and 2.7 nM for S3
12K mutant receptors. The mutant receptors were constitutively active,
stimulating PI hydrolysis in the absence of agonist. S312F and S312K
mutations resulted in twofold and five-fold increases, respectively, i
n basal levels of PI hydrolysis. Mianserin and mesulergine displayed i
nverse agonist activity by decreasing basal levels of PI hydrolysis st
imulated by S312K mutant receptors. [H-3]5-HT and [H-3]-mesulergine la
beled the same number of S312K mutant receptors and 5'-guanylylimidodi
phosphate had no effect on [H-3]5-HT binding. These results indicate t
hat serine --> lysine mutation at amino acid no. 312 produces an agoni
st high-affinity slate of the 5-HT2C receptor that spontaneously coupl
es to G proteins and stimulates PI hydrolysis in the absence of agonis
t.